$BAVA

Common Shares of Beneficial Interest of Bitwise Avalanche ETF

1
0
0
Low

Avalanche Staking ETF Draws Attention as Remittix Opens PayFi to 1,000 Holders

Bitwise's Avalanche (AVAX) ETF (BAVA) began trading in April 2026, offering staking rewards and liquidity. AVAX traded near $11.15 in early October. Remittix invites 1,000 RTX holders to test PayFi, a service converting crypto to fiat, aiming to capture global remittance market share. RTX is set to launch on November 24 after a $0.46 presale stage.

Bavarian Nordic shares rise after Tarja Stenvall named new CEO

Bavarian Nordic shares rose 2.5% after appointing Tarja Stenvall as CEO, effective Oct. 15. Stenvall has extensive pharma experience at Sanofi, AstraZeneca, and Pfizer. Board Chair Anne Louise Eberhard cited her global leadership background. Stenvall aims to expand the company's vaccine reach and market position. Paul Chaplin, the outgoing CEO, was thanked for his contributions.

Bavarian Nordic Posts Strong First Half, Travel Health Drives Growth; Stock Up

Bavarian Nordic (BAVA) reported Q2 2026 revenue of DKK 2,034 million, up 23% YoY, driven by Travel Health and Public Preparedness segments. EBITDA was DKK 925 million with a 45% margin. The company raised full-year guidance, expecting DKK 5,700 million revenue and 30% EBITDA margin. BAVA's stock is up 8.34% to DKK 208.00.

BAVA sentiment & insider activity

Over the past 7 days, AlphAI's AI scored 1 news story mentioning BAVA (Common Shares of Beneficial Interest of Bitwise Avalanche ETF). Coverage has skewed bullish: 1 bullish, 0 neutral, and 0 bearish.

Recent BAVA coverage spans corporate actions, earnings and crypto.

What's driving BAVA

AlphAI scores every news story that mentions BAVA with an AI model for sentiment and relevance, and aggregates insider trades from Common Shares of Beneficial Interest of Bitwise Avalanche ETF's SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $BAVA

Score
$BAVAMed

Bavarian Nordic shares rise after Tarja Stenvall named new CEO

Bavarian Nordic shares rose 2.5% after appointing Tarja Stenvall as CEO, effective Oct. 15. Stenvall has extensive pharma experience at Sanofi, AstraZeneca, and Pfizer. Board Chair Anne Louise Eberhard cited her global leadership background. Stenvall aims to expand the company's vaccine reach and market position. Paul Chaplin, the outgoing CEO, was thanked for his contributions.

$BAVAHighAI 8/10

Why is Bavarian Nordic stock surging today?

Bavarian Nordic's stock rose 7.9% to 207.2 DKK after reporting H1 2026 results. Q2 revenue increased 23% to DKK 2,034 million, with EBITDA at DKK 925 million. The company raised its full-year revenue guidance to DKK 5,700 million and EBITDA margin target to 30%. Strong performance was driven by Travel Health revenue growth and a new government contract. A share buyback program of up to DKK 750 million was also announced.

Bavarian Nordic A/S: Bavarian Nordic to Launch New Share Buy-back Program of up to DKK 750 Million

Bavarian Nordic A/S (OMX: BAVA) announced a new share buy-back program of up to DKK 750 million, starting in Q3 2026. The program aims to adjust capital structure and create shareholder value. The company also plans to terminate its DKK 1 billion revolving credit facility, citing it as unnecessary for day-to-day operations. Bavarian Nordic holds 3,558,591 treasury shares, or 4.49% of its share capital, as of July 2026.

Bavarian Nordic - Completion of Share Buy-Back Program

Bavarian Nordic A/S (OMX: BAVA) said its June 2, 2026 share buy-back program is complete. The company repurchased 820,607 shares for about DKK 150 million, the third tranche of a planned up to DKK 500 million in 2026, and will hold them as treasury stock. It now holds 3,558,591 treasury shares, 4.49% of share capital.

$BAVAMedAI 8/10

Bavarian Nordic Launches Next Tranche of Share Buy-Back Program

Bavarian Nordic A/S (OMX: BAVA) said it has started the third and final tranche of its 2026 share buy-back, authorized at its April 21, 2026 AGM. The company plans to repurchase up to DKK 150 million (max 1,500,000 shares) as treasury stock, completing by July 10. Earlier tranches totaled DKK 350 million completed in May. Nordea will execute the trades.